DG vs TERN · P/E 15, rev $40.61B vs $6.12B cap
Dollar General Corporation (DG) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported DG revenue for 2025-01-31 was $40.61B. Net income was $1.13B. Revenue was up 5.0% from 2024-02-02 to 2025-01-31. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
DG currently screens at market cap $22.87B and trailing P/E 14.7. TERN currently screens at market cap $6.12B.
Not investment advice. Open the DG and TERN stock pages for the full models.
Not investment advice.